A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families

被引:0
|
作者
Serova, O
Montagna, M
Torchard, D
Narod, SA
Tonin, P
Sylla, B
Lynch, HT
Feunteun, J
Lenoir, GM
机构
[1] INT AGCY RES CANC,F-69372 LYON,FRANCE
[2] INST GUSTAVE ROUSSY,VILLEJUIF,FRANCE
[3] MCGILL UNIV,DEPT MED,DIV MED GENET,MONTREAL,PQ,CANADA
[4] MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA
[5] CREIGHTON UNIV,SCH MED,DEPT PREVENT MED & PUBL HLTH,OMAHA,NE
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We have analyzed 20 breast-ovarian cancer families, the majority of which show positive evidence of linkage to chromosome 17q12, for germ-line mutations in the BRCA1 gene. BRCA1 mutations cosegregating with breast and ovarian cancer susceptibility were identified in 16 families, including 1 family with a case of male breast cancer. Nine of these mutations have not been reported previously. The majority of mutations were found to generate a premature stop codon leading to the formation of a truncated BRCA1 protein of 2%-88% of the expected normal length. Two mutations altered the RING finger domain. Sequencing of genomic DNA led to the identification of a mutation in the coding region of BRCA1 in 12 families, and cDNA analysis revealed an abnormal or missing BRCA1 transcript in 4 of the 8 remaining families. A total of eight mutations were associated with a reduced quantity of BRCA1 transcript. We were unable to detect BRCA1 mutations in 4 of the 20 families, but only 1 of these was clearly linked to BRCA1. Ir is expected that the majority of clear examples of the breast-ovarian cancer syndrome will be associated with germ-line mutations in the coding region of BRCA1.
引用
收藏
页码:42 / 51
页数:10
相关论文
共 50 条
  • [1] Founder mutations in the BRCA1 gene in polish families with breast-ovarian cancer
    Górski, B
    Byrski, T
    Huzarski, T
    Jakubowska, A
    Menkiszak, J
    Gronwald, J
    Pluzanska, A
    Bebenek, M
    Fischer-Maliszewska, L
    Grzybowska, E
    Narod, SA
    Lubinski, J
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (06) : 1963 - 1968
  • [2] High Incidence of 4153delA BRCA1 Gene Mutations in Lithuanian Breast- and Breast-ovarian Cancer Families
    Jacek Gronwald
    Pavel Elsakov
    Bohdan Górski
    Jan Lubiński
    Breast Cancer Research and Treatment, 2005, 94 : 111 - 113
  • [3] High incidence of 4153delA BRCA1 gene mutations in Lithuanian breast- and breast-ovarian cancer families
    Gronwald, J
    Elsakov, P
    Górski, B
    Lubinski, J
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 (02) : 111 - 113
  • [4] Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer
    Ramus, SJ
    KoteJarai, Z
    Friedman, LS
    VanderLooij, M
    Gayther, SA
    Csokay, B
    Ponder, BA
    Olah, E
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (05) : 1242 - 1246
  • [5] A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region
    ZeladaHedman, M
    Arver, BW
    Claro, A
    Chen, JD
    Werelius, B
    Kok, H
    Sandelin, K
    Hakansson, S
    Andersen, TI
    Borg, A
    Dale, ALB
    Lindblom, A
    CANCER RESEARCH, 1997, 57 (12) : 2474 - 2477
  • [6] Founder mutations in the BRCA1 gene in west Belarusian breast-ovarian cancer families
    Oszurek, O
    Gorski, B
    Gronwald, J
    Prosolow, Z
    Uglanica, K
    Murinow, A
    Bobko, I
    Downar, O
    Zlobicz, M
    Norik, D
    Byrski, T
    Jakubowska, A
    Lubinski, J
    CLINICAL GENETICS, 2001, 60 (06) : 470 - 471
  • [7] A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families
    Vahteristo, P
    Eerola, H
    Tamminen, A
    Blomqvist, C
    Nevanlinna, H
    BRITISH JOURNAL OF CANCER, 2001, 84 (05) : 704 - 708
  • [8] A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families
    P Vahteristo
    H Eerola
    A Tamminen
    C Blomqvist
    H Nevanlinna
    British Journal of Cancer, 2001, 84 : 704 - 708
  • [9] Identification of breast-ovarian cancer families without BRCA1 or BRCA2 mutations.
    Unger, M
    Nathanson, KL
    Antin-Ozerkis, D
    Martin, AM
    Shih, HA
    Calzone, KA
    Ward, T
    Mazoyer, S
    Rebbeck, T
    Weber, BL
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A328 - A328
  • [10] Cancer prevalence in 129 breast-ovarian cancer families tested for BRCA1 and BRCA2 mutations
    Schlebusch, C. M.
    Dreyer, G.
    Sluiter, M. D.
    Yawitch, T. M.
    van den Berg, H. J.
    van Rensburg, E. J.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2010, 100 (02): : 113 - 117